Sodium rabeprazole enteric-coated tablets are usually taken orally as 10 mg once daily for adults, or 20 mg once daily depending on the condition.This can be increased to twice a day when once a day is not effective for the treatment of GERD, and twice a day is required for the eradication of Helicobacter pylori. In general, the drug is given for up to 8 weeks for gastric ulcers, anastomotic ulcers, and reflux esophagitis, and for up to 6 weeks for duodenal ulcers. The drug should be used under medical supervision. Rabeprazole sodium enteric-coated tablets are mainly used for the treatment of gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux esophagitis, and Drewe-Ayer’s syndrome. Adverse reactions such as shock, decreased blood cells or platelets, hemolytic anemia, lymphopenia, diarrhea and abdominal distension, dyspepsia, weakness of the limbs, dizziness, and dizziness may occur after taking this product. It is contraindicated in patients with hypersensitivity to rabeprazole sodium or any of the ingredients in the prescription, and is contraindicated in lactating women. Use with caution in patients with a history of drug allergy, patients with hepatic dysfunction, and patients of advanced age. If you need to use rabeprazole sodium enteric-coated tablets, please consult a professional doctor, follow the doctor’s instructions, and use medication reasonably.